News

Glenmark Pharmaceuticals announced on Tuesday that it will commence another new Phase 3 clinical trial on a combination of two anti-viral drugs Favipiravir and Umifenovir in hospitalized patients of moderate COVID-19 in India. Glenmark has received approval from the...

AstraZeneca will collaborate with ArcherDX, a genomic analysis company focused on precision oncology, to use personalised cancer monitoring to detect minimal residual disease (MRD) in patients with early-stage non-small cell lung cancer (NSCLC). ArcherDX’s personalised assay will be used in...

SIRIO Europe (Ayanda) – the European headquarters of the SIRIO Group, a global nutraceutical contract development, innovation and manufacturing organization (CDiMO) – says considerable worldwide demand for immunity products has accelerated in recent months due coronavirus, but it is...

US pharmaceutical giant Gilead Sciences is likely to apply to India's Central Drugs Standard Control Organisation (CDSCO) soon seeking marketing authorisation for its anti-viral drug remdesivir, which is being considered by many as a potential medication for COVID-19. Officials of...

Pfizer has reported new data from the Phase Ib clinical trial of PF-06939926 for the treatment of patients with Duchenne muscular dystrophy (DMD). PF-06939926 is an experimental, recombinant adeno-associated virus serotype 9 (AAV9) capsid with a shortened variant of the...

Clinigen Group has signed an exclusive agreement with Xeris Pharmaceuticals to manage the supply and distribution of Gvoke injection, a treatment for diabetes, outside the US. Under the terms of the supply and distribution agreement with Xeris, Clinigen will provide...

Parexel announced the deployment of nearly 30 employee volunteers to help administer and oversee COVID-19 testing across the UK in partnership with the Association of Clinical Research Organizations (ACRO). The Parexel volunteers are among a team of 150 individuals with...